MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.

Molecular Cancer
Ondrej SlabyRostislav Vyzula

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs 18-25 nucleotides in length that downregulate gene expression during various crucial cell processes such as apoptosis, differentiation and development. Changes in the expression profiles of miRNAs have been observed in a variety of human tumors, including colorectal cancer (CRC). Functional studies indicate that miRNAs act as tumor suppressors and oncogenes. These findings significantly extend Vogelstein's model of CRC pathogenesis and have shown great potential for miRNAs as a novel class of therapeutic targets. Several investigations have also described the ability of miRNA expression profiles to predict prognosis and response to selected treatments in CRC patients, and support diagnosis of CRC among cancer of unknown primary site. miRNAs' occurrence has been repeatedly observed also in serum and plasma, and miRNAs as novel minimally invasive biomarkers have indicated reasonable sensitivity for CRC detection and compare favorably with the fecal occult blood test. In this review, we summarize the knowledge regarding miRNAs' functioning in CRC while emphasizing their significance in pathogenetic signaling pathways and their potential to serve as disease biomarkers and novel therapeut...Continue Reading

References

Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Jul 12, 2002·Nature·Carina Dennis
Feb 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Mar 16, 2005·Cell·Steven M JohnsonFrank J Slack
Jun 10, 2005·Nature·Jun LuTodd R Golub
Nov 1, 2005·Nature·Jan KrützfeldtMarkus Stoffel
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Mar 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jordan M CumminsVictor E Velculescu
Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
May 3, 2006·Biological & Pharmaceutical Bulletin·Yukihiro AkaoTomoki Naoe
May 16, 2006·Journal of Gastroenterology·Tetsuji TakayamaYoshiro Niitsu
Aug 1, 2006·Nature Genetics·Michael DewsAndrei Thomas-Tikhonenko
Oct 31, 2006·Trends in Molecular Medicine·Ramiro GarzonCarlo M Croce
Dec 1, 2006·The Journal of Biological Chemistry·Keith WoodsScott M Hammond
Jun 2, 2007·Molecular Cell·Tsung-Cheng ChangJoshua T Mendell
Jun 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Scott ShellMarcus E Peter
Jul 28, 2007·Current Biology : CB·Guido T BommerEric R Fearon
Aug 19, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Lorena RossiIsabella Faraoni
Aug 25, 2007·Molecular Cancer·Giovanni LanzaMassimo Negrini
Sep 11, 2007·The Journal of Biological Chemistry·Bin ShiRenato Baserga
Sep 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi TazawaHitoshi Nakagama
Oct 5, 2007·Nature Reviews. Cancer·Lin HeGregory J Hannon
Nov 13, 2007·Cancer Cell·Heiko Hermeking
Dec 20, 2007·Journal of Cellular and Molecular Medicine·Baohong Zhang, M A Farwell
Jan 31, 2008·JAMA : the Journal of the American Medical Association·Aaron J SchetterCurtis C Harris
Mar 14, 2008·The New England Journal of Medicine·Fortunato Ciardiello, Giampaolo Tortora
Mar 26, 2008·Nature Biotechnology·Nitzan RosenfeldIris Barshack
Mar 29, 2008·Cancer Gene Therapy·A W Tong, J Nemunaitis
Apr 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kazuo MotoyamaMasaki Mori
May 15, 2008·Carcinogenesis·Kexin ChenWei Zhang
Jul 2, 2008·Molecular and Cellular Biology·Galina GabrielyAnna M Krichevsky
Jul 9, 2008·Cell Research·Mariano MonzoJesus Garcia-Foncillas
Jul 9, 2008·World Journal of Gastroenterology : WJG·Ammar NatalwalaChris Tselepis
Jul 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Patrick S MitchellMuneesh Tewari

❮ Previous
Next ❯

Citations

Apr 6, 2012·International Journal of Colorectal Disease·Petra FaltejskovaOndrej Slaby
Feb 9, 2011·Parasitology Research·Saleh Al-QuraishyMohamed Abdel Monam Dkhil
Jun 29, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Anne-Laure PinJacques Huot
Nov 15, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Martina RedovaOndrej Slaby
Feb 15, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Keiichi HizakiYasuhisa Shinomura
Jun 8, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Zuanel DiazGerald Batist
May 7, 2011·Journal of Pediatric Gastroenterology and Nutrition·Adam M ZahmJoshua R Friedman
Jan 12, 2012·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·Donato F AltomareSimona Giuratrabocchetta
Oct 27, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jinliang XingHushan Yang
Oct 25, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eduardo VilarStephen B Gruber
May 23, 2012·Journal of Translational Medicine·Jiri SanaOndrej Slaby
Jun 22, 2012·Journal of Translational Medicine·Muhammad Imran AslamJames Howard Pringle
Mar 24, 2012·Journal of Translational Medicine·Martina RedovaOndrej Slaby
Jan 16, 2014·Cancer Management and Research·Mary Nugent
Jun 22, 2012·World Journal of Gastroenterology : WJG·Renata HezovaOndrej Slaby
Jan 8, 2014·Theranostics·Thillai V SekarRamasamy Paulmurugan
Oct 16, 2010·Biomarkers in Medicine·Upender ManneHarvey L Bumpers
Sep 22, 2012·Pathology Research International·Rani KanthanSelliah Chandra Kanthan
Feb 25, 2014·Journal of Translational Medicine·Claudia RubieMathias Glanemann
Nov 23, 2013·Carcinogenesis·Hongchao ZhaoMinhua Zheng
Dec 26, 2013·Experimental and Molecular Pathology·Faeza EbrahimiAlfred King-Yin Lam
Sep 10, 2014·BMC Cancer·Sonia Molina-PineloRocio Garcia-Carbonero
Jun 10, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·So-Yeon ParkKyung Keun Kim

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotides
PCR

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Annual Review of Medicine
Ramiro GarzonCarlo M Croce
International Journal of Cancer. Journal International Du Cancer
Zhaohui HuangXiang Du
JAMA : the Journal of the American Medical Association
Aaron J SchetterCurtis C Harris
The American Journal of Pathology
Kristina ScheeKjersti Flatmark
© 2022 Meta ULC. All rights reserved